← Leaderboards
Eliot Blatt
Ut Southwestern Medical Center
$112,526
Attributed
$112,526
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $40.4K · FY2020–22$50K$37.5K$25K$12.5K$0
'20
'21
'22
Funding mix
By agency
NIH$112,526 · 1
By mechanism
F31$112,526 · 1
Top collaborators
No co-investigators on record.
Most similar at Ut Southwestern Medical Center
Same institution · by research overlap
- Zhi-Ping Liu$6,770,219
- Samuel Kent McBrayer$5,142,431
- Ram Shankar Mani$3,200,669
- Salma Kaochar$2,491,907
- Kalil G Abdullah$1,835,946
Others in their field
Other Emerging Leaders on “Evolution”
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Scott Hensley · University Of Pennsylvania$49,758,212
- Laura Ferrarese · Association Of Universities For Research In Astronomy, Inc.$47,742,424
- S. Mark Tompkins · University Of Georgia$20,806,329
- Walter Orenstein · Emory University$15,988,348
- Andrew Pekosz · Johns Hopkins University$15,027,681
Research focus
EvolutionAblationAntioxidantsAndrogen ReceptorAutomobile DrivingBioinformaticsCancer CellCancer PatientCastration Resistant Prostate CancerApoptosisCellsCell SurvivalClinicClinically RelevantCollectionComparativeCrispr/Cas TechnologyDependenceDisease ProgressionDrug ResistanceCell LineEnzyme Inhibitor DrugsEnzymesFluorescence Microscopy
Grant awards (3)
Metabolic alterations contributing to enzalutamide resistance in prostate cancer$32,302
F31 · FY2022 · CA · contact PI
Metabolic alterations contributing to enzalutamide resistance in prostate cancer$40,370
F31 · FY2021 · CA · contact PI
Metabolic alterations contributing to enzalutamide resistance in prostate cancer$39,854
F31 · FY2020 · CA · contact PI